Literature DB >> 2827974

Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients.

I Berlin1, A Grimaldi, C Payan, C Sachon, F Bosquet, F Thervet, A J Puech.   

Abstract

Thirty-seven insulin-dependent diabetic patients were tested for symptoms of hypoglycemia, cardiac autonomic neuropathy (i.e., heart rate variation during deep breathing, Valsalva maneuver, immediate heart rate response to standing), and isoproterenol sensitivity (defined as the dose of isoproterenol required to increase heart rate by 25 beats/min: I25). Tests of cardiac autonomic neuropathy showed no relation to hypoglycemic symptoms. On the contrary, a clear relationship could be established between isoproterenol sensitivity and adrenergic symptoms of hypoglycemia. Diabetic patients with decreased response to isoproterenol had fewer adrenergic symptoms, perceived hypoglycemia at a lower blood glucose level, and had more hypoglycemic accidents. Symptoms most related to isoproterenol sensitivity were tremor, sweaty palms, and hunger. With the isoproterenol-sensitivity test a distinction could be made between the groups at high (I25 greater than 3 micrograms) and low (I25 less than 3 micrograms) risk for hypoglycemic accidents. We suggest that the isoproterenol-sensitivity test could be used to identify diabetic patients at increased risk for hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827974     DOI: 10.2337/diacare.10.6.742

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 2.  Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus.

Authors:  Geremia B Bolli
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

3.  Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones.

Authors:  D Kerr; I A Macdonald; R B Tattersall
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

4.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

5.  Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Authors:  Oleg Otlivanchik; Nicole M Sanders; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-28       Impact factor: 3.619

6.  Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia.

Authors:  T S Trovik; A Vaartun; R Jorde; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness.

Authors:  T S Trovik; R Jaeger; R Jorde; G Sager
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

8.  Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats.

Authors:  Rawad Farhat; Eliane de Santana-Van Vliet; Gong Su; Levi Neely; Thea Benally; Owen Chan
Journal:  Endocrinol Diabetes Metab       Date:  2021-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.